Programme
THIS IS A PRELIMINARY PROGRAMME AND IS SUBJECT TO CHANGE.
WEDNESDAY 9TH NOVEMBER 2016 |
||
14:00 – 15:00 |
Registration & Reception |
|
14:00 – 14:45 |
Group Welcome Lunch |
|
CANCER METABOLISM |
||
14:45 – 15:00 |
Opening Comments |
|
15:00 – 15:30 |
Michael Lisanti |
CANCER METABOLISM AND TUMOR HETEROGENEITY: MITOCHONDRIA IN CANCER STEM CELLS ARE A THERAPEUTIC TARGET |
15:30 – 16:00 |
Adrian Harris |
INTRATUMOUR HETEROGENEITY OF THE HYPOXIA RESPONSE, ROLES IN INVASION, METABOLISM, STEM CELL BIOLOGY AND DRUG RESPONSE |
16:00 – 16:30 |
Arne Ostman |
CAFS AND PERIVASCULAR CELLS; IMPACT ON PROGNOSIS AND RESPONSE TO TREATMENT |
16:30 – 17:00 |
Dr. Jacques Pouyssegur |
TARGETING BIOENERGETICS AND NUTRIENT SENSING IN HYPOXIC TUMOURS |
17:00 – 17:30 |
Refreshments |
|
METABOLIC SYMBIOSIS AND REPROGRAMMING |
||
17:30 – 18:00 |
Ubaldo E. Martinez Outschoorn |
HUMAN METABOLIC ECOSYSTEMS |
18:00 – 18:30 |
Pierre Sonveaux |
POSITIONING AUTOPHAGY IN THE METABOLIC SYMBIOSIS BASED ON THE EXCHANGE OF LACTATE BETWEEN OXIDATIVE AND GLYCOLYTIC CANCER CELLS |
18:30 – 19:00 |
Lluis Fajas |
CELL CYCLE REGULATORS ARE MAJOR FACTORS IN ADAPTING THE METABOLIC RESPONSE TO CANCER |
19:00 – 19:30 |
Isaac Witz |
ASTROCYTES, BRAIN ENDOTHELIAL CELLS AND MICROGLIA RESPOND EQUALLY TO BRAIN-METASTASIZING MELANOMA CELLS AND TO STROKE |
19:30 – 20:00 |
PM Panel Discussion |
|
20:00 |
Group Dinner |
THURSDAY 10TH NOVEMBER 2016 |
||
07:00 – 08:30 |
Group Breakfast |
|
METABOLISM, AUTOPHAGY AND THE TUMOR MICROENVIRONMENT |
||
08:30 – 09:00 |
Federica Sotgia |
UNDERSTANDING THE ROLE OF TELOMERASE IN CANCER STEM CELLS |
09:00 – 09:30 |
Michelangelo Campanella |
THE 18KDA PROTEIN TSPO INHIBITS MITOCHONDRIAL AUTOPHAGY AND UNDERPINS METABOLIC REPROGRAMMING OF BREAST CANCER CELLS |
09:30 – 10:00 |
Myriam Fabre |
TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE |
10:00 – 10:30 |
Refreshments |
|
10:30 – 11:00 |
Balázs GyÅ‘rffy |
LINKING TP53 MUTATION TO ENERGY METABOLISM AND INCREASED GLYCOLYSIS IN BREAST CANCER |
11:00 – 11:30 |
Ana Urbano |
METABOLIC ALTERATIONS PRODUCED BY HEXAVALENT CHROMIUM: INSIGHTS INTO THE MOLECULAR MECHANISMS UNDERLYING ITS CARCINOGENICITY |
11:30 – 12:00 |
AM Panel Discussion |
|
12:00 – 16:30 |
Group Lunch & Free Time |
|
13:00 – 16:00 |
Group Activity: Paphos Tombs of the Kings – Mosaics – Aphrodite’s Rock |
|
NEW PROMISING TARGETS AND STRATEGIES FOR CANCER THERAPY |
||
16:30 – 17:00 |
Mark Musters |
TARGETING TUMOUR METABOLISM BY INHIBITION OF NUCLEAR RECPTOR ERRα WITH SMALL MOLECULAR COMPOUNDS |
17:00 – 17:30 |
Balamurugan Kuppusamy |
THE CEBPD TRANSCRIPTION FACTOR, A MARKER OF GOOD PROGNOSIS IN BREAST CANCER, BECOMES A SIGNALING HUB FOR PROMOTION OF CANCER CELL STEMNESS BY HYPOXIA AND INTERLEUKIN-6 |
17:30 – 18:00 |
Matthew Hirschey |
ACTIVATING LIPID METABOLISM AS A CANCER THERAPY |
18:00 – 18:30 |
Refreshments |
|
18:30 – 19:00 |
Derek Radisky |
EPITHELIAL AND STROMAL ALTERATIONS THAT DRIVE BREAST CANCER PROGRESSION FROM BENIGN BREAST DISEASE |
19:00 – 19:30 |
Paola Marignani |
IS METABOLISM THE INTERCEPT BETWEEN TUMOUR MICROENVIRONMENT AND EPIGENETIC CHANGES THAT SUPPORT CANCER? |
19:30 – 20:00 |
PM Panel Discussion |
|
20:00 |
Group Dinner |
FRIDAY 11TH NOVEMBER 2016 |
||
07:00 – 08:30 |
Group Breakfast |
|
INFLAMMATION AND CANCER PROGRESSION |
||
08:30 – 09:00 |
Petr Benes |
SUPPRESSION OF BREAST CANCER LUNG METASTASES BY INFLAMMATORY SIGNATURE TARGETED BY c-MYB |
09:00 – 09:30 |
Adit Ben-Baruch |
INFLAMMATION-DRIVEN TUMOR-STROMA INTERACTIONS IN BREAST CANCER: REGULATION OF METABOLIC AND PRO-TUMORAL TRAITS OF MESENCHYMAL STEM CELLS |
09:30 – 10:00 |
Si Chen |
INFLAMMATORY NICHE SIGNALLING DRIVES GENOTOXIC STRESS IN HEMATOPOIETIC STEM CELLS AND PREDICTS LEUKEMIC EVOLUTION IN HUMAN LEUKEMIA PREDISPOSITION SYNDROMES |
10:00 – 10:30 |
AM Panel Discussion |
|
10:30 – 11:00 |
Refreshments |
|
11:45 – 17:00 |
Group Lunch & Free Time |
|
12:45 – 16:30 |
Group Activity: Wine Tasting at Chryssogoriatissa Monasteries – Agios Neophytos |
|
MITOCHONDRIA IN CANCER PATHOGENESIS |
||
17:00 – 17:30 |
Mike Berridge |
MITOCHONDRIAL TRANSFER FROM THE MICROENVIRONMENT FACILITATES GROWTH AND METASTASIS OF TUMOUR CELLS WITHOUT MITOCHONDRIAL DNA |
17:30 – 18:00 |
Igal Madar |
18F-FBNTP - A NOVEL BIOMARKER FOR DIFFERENTIAL IMAGING OF OXIDATIVE AND NON-OXIDATIVE MICROREGIONS IN BREAST TUMOR |
18:00 – 18:30 |
PM Panel Discussion |
|
18:30 – 19:30 |
Refreshments |
|
20:00 |
*Gala Dinner & Group Photo* |
SATURDAY 12TH NOVEMBER 2016 |
||
07:00 – 08:30 |
Group Breakfast |
|
MYC AND INTEGRINS AS THERAPEUTIC TARGETS |
||
08:30 – 09:00 |
Juha Klefstrom |
REACTIVATING MYC APOPTOSIS PATHWAY IN BREAST CANCER
|
09:00 – 09:30 |
Jai Prakash |
INTEGRIN ALPHA5: A KEY PROGNOSTIC AND THERAPEUTIC TARGET IN PANCREATIC TUMOR STROMA |
09:30 – 09:45 |
Maria Rosaria Ambrosio |
GLUCOSE IMPAIRS TAMOXIFEN RESPONSIVENESS MODULATING CTGF (Connective Tissue Growth Factor) IN BREAST CANCER CELLS |
09:45 – 10:00 |
Vadim Pokrovsky |
ANTICANCER ACTIVITY OF L-LYSINE ALPHA-OXIDASE FROM TRICHODERMA CF. AUREOVIRIDE RIFAI |
10:00 – 10:30 |
AM Panel Discussion |
|
10:30 – 10:45 |
Closing Comments |
|
10:45 – 11:45 |
Refreshments |